How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation
- 17 November 2014
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 168 (4) , 481-491
Abstract
Summary: Sinusoidal obstruction syndrome (SOS), also called veno‐occlusive disease of the liver, is one of the most relevant complications of endothelial origin that appears early after haematopoietic cell transplantation (HCT). Despite its relatively low incidence and the fact that most cases of SOS resolve spontaneously, the cases that evolve to multi‐organ failure (MOF; severe SOS) have a mortality rate higher than 80% and represent one of the major clinical problems after HCT. For this reason, transplantation teams must have a pre‐established policy regarding preventive measures in high‐risk patients, strict daily control of weight and fluid balance during HCT, homogeneous diagnostic criteria, appropriate complementary studies for a correct differential diagnosis and measures to prevent and manage hepatorenal syndrome; in addition they must also be ready to start early treatment with defibrotide in patients with a possible severe SOS. Due to the lack of definitive evidence to enable the establishment of general recommendations in the management of SOS, this review analyses all of these aspects based on the author's personal experience.Keywords
This publication has 79 references indexed in Scilit:
- Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive diseaseTherapeutic Advances in Hematology, 2012
- The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last DecadeTransplantation and Cellular Therapy, 2011
- The role of the endothelium in the short-term complications of hematopoietic SCTBone Marrow Transplantation, 2011
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial InjuryTransplantation and Cellular Therapy, 2010
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding TrialTransplantation and Cellular Therapy, 2010
- Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeTransplantation and Cellular Therapy, 2010
- Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantationBlood, 2008
- On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive diseaseAnnals of Hematology, 1993
- Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosisHepatology, 1991